M&A Deal Summary

Soluble Therapeutics Acquires Dilyx Biotechnologies

On October 1, 2014, Soluble Therapeutics acquired life science company Dilyx Biotechnologies

Acquisition Highlights
  • This is Soluble Therapeutics’ 1st transaction in the Life Science sector.
  • This is Soluble Therapeutics’ 1st transaction in the United States.
  • This is Soluble Therapeutics’ 1st transaction in Washington.

M&A Deal Summary
Date 2014-10-01
Target Dilyx Biotechnologies
Sector Life Science
Buyer(s) Soluble Therapeutics
Deal Type Add-on Acquisition

Target

Dilyx Biotechnologies

Seattle, Washington, United States
Dilyx Biotechnologies LLC develops protein solubility kits.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Soluble Therapeutics

Birmingham, Alabama, United States
Category Company
Sector Life Science
DESCRIPTION

Soluble Therapeutics, Inc. specializes in the formulation optimization of protein-based therapeutics and vaccines on a contract basis for pharmaceutical, biotech, and vaccine companies.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Washington) 1 of 1
Country (United States) 1 of 1
Year (2014) 1 of 1
Mergr

Product

Company

Legal